Expansion of CD4+CD25+ suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads

Human Immunology

Volumn 68, Issue 6, 2007, Pages 478-490

  Gansuvd, Balgansuren ^a   Asiedu, Clement K ^a   Goodwin, Jeanine ^a   Jargal, Uuganbayar ^a   Deckard, Lindsey A ^a   Andrades, Patricio ^a   Guarcello, Vincenzo ^b   Thomas, Judith M ^a  

^a Kentucky   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

CD4+CD25+ Tregs expansion; FOXP3; Memory; Nonhuman primate; Rhesus macaques

Indexed keywords

CD28 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR7; FAS ANTIGEN; L SELECTIN; TRANSCRIPTION FACTOR FOXP3;

ALLERGY; ALLOGRAFT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; IN VITRO STUDY; INFECTION; MACACA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSPLANTATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD4; DIPHTHERIA TOXIN; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; MICROSPHERES; MODELS, ANIMAL; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES, REGULATORY;

EID: 34248394243     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.02.011     Document Type: Article

References (48)

1. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155 (1995) 1151-1164
2. Sanchez-Fueyo A., Weber M., Domenig C., Strom T.B., and Zheng X.X. Tracking the immunoregulatory mechanisms active during allograft tolerance. J Immunol 168 (2002) 2274-2281
3. Suri-Payer E., Amar A.Z., Thornton A.M., and Shevach E.M. CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160 (1998) 1212-1218
4. Baecher-Allan C., Brown J.A., Freeman G.J., and Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167 (2001) 1245-1253
5. Thornton A.M., and Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 164 (2000) 183-190
6. Taams L.S., Smith J., Rustin M.H., Salmon M., Poulter L.W., and Akbar A.N. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 31 (2001) 1122-1131
7. Wing K., Ekmark A., Karlsson H., Rudin A., and Suri-Payer E. Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood. Immunology 106 (2002) 190-199
8. Szanya V., Ermann J., Taylor C., Holness C., and Fathman C.G. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 169 (2002) 2461-2465
9. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
10. McHugh R.S., Whitters M.J., Piccirillo C.A., Young D.A., Shevach E.M., Collins M., and Byrne M.C. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16 (2002) 311-323
11. Stephens L.A., Mottet C., Mason D., and Powrie F. Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 31 (2001) 1247-1254
12. Dieckmann D., Plottner H., Berchtold S., Berger T., and Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193 (2001) 1303-1310
13. Levings M.K., Gregori S., Tresoldi E., Cazzaniga S., Bonini C., and Roncarolo M.G. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells. Blood 105 (2005) 1162-1169
14. Thornton A.M., and Shevach E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 188 (1998) 287-296
15. Sadlack B., Lohler J., Schorle H., Klebb G., Haber H., Sickel E., Noelle R.J., and Horak I. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol 25 (1995) 3053-3059
16. Thornton A.M., Donovan E.E., Piccirillo C.A., and Shevach E.M. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 172 (2004) 6519-6523
17. Nakamura K., Kitani A., Fuss I., Pedersen A., Harada N., Nawata H., and Strober W. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172 (2004) 834-842
18. Stassen M., Fondel S., Bopp T., Richter C., Muller C., Kubach J., Becker C., Knop J., Enk A.H., Schmitt S., Schmitt E., and Jonuleit H. Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 34 (2004) 1303-1311
19. Maloy K.J., Salaun L., Cahill R., Dougan G., Saunders N.J., and Powrie F. CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med 197 (2003) 111-119
20. Zhang X., Koldzic D.N., Izikson L., Reddy J., Nazareno R.F., Sakaguchi S., Kuchroo V.K., and Weiner H.L. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 16 (2004) 249-256
21. Hoffmann P., Eder R., Kunz-Schughart L.A., Andreesen R., and Edinger M. Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104 (2004) 895-903
22. Godfrey W.R., Ge Y.G., Spoden D.J., Levine B.L., June C.H., Blazar B.R., and Porter S.B. In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104 (2004) 453-461
23. Gansuvd B., Hubbard W.J., Hutchings A., Thomas F.T., Goodwin J., Wilson S.B., Exley M.A., and Thomas J.M. Phenotypic and functional characterization of long-term cultured rhesus macaque spleen-derived NKT cells. J Immunol 171 (2003) 2904-2911
24. Asiedu C., Meng Y., Wang W., Huang Z., Contreras J.L., George J.F., and Thomas J.M. Immunoregulatory role of CD8alpha in the veto effect. Transplantation 67 (1999) 372-380
25. Hofmann-Lehmann R., Williams A.L., Swenerton R.K., Li P.L., Rasmussen R.A., Chenine A.L., McClure H.M., and Ruprecht R.M. Quantitation of simian cytokine and beta-chemokine mRNAs, using real-time reverse transcriptase-polymerase chain reaction: variations in expression during chronic primate lentivirus infection. AIDS Res Hum Retroviruses 18 (2002) 627-639
26. Earle K.E., Tang Q., Zhou X., Liu W., Zhu S., Bonyhadi M.L., and Bluestone J.A. In vitro expanded human CD4+CD25+ regulatory T cells suppress effector T cell proliferation. Clin Immunol 115 (2005) 3-9
27. Hoffmann P., Eder R., Boeld T.J., Doser K., Piseshka B., Andreesen R., and Edinger M. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 108 (2006) 4260-4267
28. Pitcher C.J., Hagen S.I., Walker J.M., Lum R., Mitchell B.L., Maino V.C., Axthelm M.K., and Picker L.J. Development and homeostasis of T cell memory in rhesus macaque. J Immunol 168 (2002) 29-43
29. de la R.M., Rutz S., Dorninger H., and Scheffold A. Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 34 (2004) 2480-2488
30. Klein L., Khazaie K., and von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 100 (2003) 8886-8891
31. Barthlott T., Moncrieffe H., Veldhoen M., Atkins C.J., Christensen J., O'Garra A., and Stockinger B. CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. Int Immunol 17 (2005) 279-288
32. Scheffold A., Huhn J., and Hofer T. Regulation of CD4+CD25+ regulatory T cell activity: it takes (IL-)two to tango. Eur J Immunol 35 (2005) 1336-1341
33. Antony P.A., Paulos C.M., Ahmadzadeh M., Akpinarli A., Palmer D.C., Sato N., Kaiser A., Hinrichs C.S., Klebanoff C.A., Tagaya Y., and Restifo N.P. Interleukin-2-dependent mechanisms of tolerance and immunity in vivo. J Immunol 176 (2006) 5255-5266
34. Cohen J.L., Trenado A., Vasey D., Klatzmann D., and Salomon B.L. CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 196 (2002) 401-406
35. Mukherjee R., Chaturvedi P., Qin H.Y., and Singh B.C.D.4+C.D.25+ r.T.c.g.i.r.t.i.B.:9-23 p.p.a.t.o.d.b.d.T.c. J Autoimmun 21 (2003) 221-237
36. Bashuda H., Kimikawa M., Seino K., Kato Y., Ono F., Shimizu A., Yagita H., Teraoka S., and Okumura K. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. J Clin Invest 115 (2005) 1896-1902
37. Suzuki H., Kundig T.M., Furlonger C., Wakeham A., Timms E., Matsuyama T., Schmits R., Simard J.J., Ohashi P.S., and Griesser H. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268 (1995) 1472-1476
38. Thornton A.M., Piccirillo C.A., and Shevach E.M. Activation requirements for the induction of CD4+CD25+ T cell suppressor function. Eur J Immunol 34 (2004) 366-376
39. Takahashi T., Kuniyasu Y., Toda M., Sakaguchi N., Itoh M., Iwata M., Shimizu J., and Sakaguchi S. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10 (1998) 1969-1980
40. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., and Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
41. Roncador G., Brown P.J., Maestre L., Hue S., Martinez-Torrecuadrada J.L., Ling K.L., Pratap S., Toms C., Fox B.C., Cerundolo V., Powrie F., and Banham A.H. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35 (2005) 1681-1691
42. Allan S.E., Passerini L., Bacchetta R., Crellin N., Dai M., Orban P.C., Ziegler S.F., Roncarolo M.G., and Levings M.K. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J Clin Invest 115 (2005) 3276-3284
43. Rosen S.D. Endothelial ligands for L-selectin: from lymphocyte recirculation to allograft rejection. Am J Pathol 155 (1999) 1013-1020
44. Cyster J.G. Chemokines and cell migration in secondary lymphoid organs. Science 286 (1999) 2098-2102
45. Delgado M., and Ganea D. VIP and PACAP enhance the in vivo generation of memory TH2 cells by inhibiting peripheral deletion of antigen-specific effectors. Arch Physiol Biochem 109 (2001) 372-376
46. Buonocore S., Van Meirvenne S., Demoor F.X., Paulart F., Thielemans K., Goldman M., and Flamand V. Dendritic cells transduced with viral interleukin 10 or Fas ligand: no evidence for induction of allotolerance in vivo. Transplantation 73 (2002) S27-S30
47. Liu W., Putnam A.L., Xu-Yu Z., Szot G.L., Lee M.R., Zhu S., Gottlieb P.A., Kapranov P., Gingeras T.R., Fazekas de St G.B., Clayberger C., Soper D.M., Ziegler S.F., and Bluestone J.A. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203 (2006) 1701-1711
48. Torrealba J.R., Katayama M., Fechner Jr. J.H., Jankowska-Gan E., Kusaka S., Xu Q., Schultz J.M., Oberley T.D., Hu H., Hamawy M.M., Jonker M., Wubben J., Doxiadis G., Bontrop R., Burlingham W.J., and Knechtle S.J. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol 172 (2004) 5753-5764